Emergent drugs to be directly supplied by makers to hospitals.

Published: 2005-10-06 06:58:00

Updated: 2005-10-06 06:58:00

An emergent or special drug having a short half life, say, 48 hours or so forth, could not be supplied through the wholesalers from its makers pursuant the current unified distribution provisions in view of its short shelf life and the time for its distribution process. In such case, the MOHW may...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK